GlassScriptPhysician profile
Adam Beyer
NPI 1457884306
$3,762.13
in general payments reported to CMS, 2019-2025
10 companies · $1,406 in 2025
The $1,406 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,356 · 2025: $1,406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,118 · Travel and Lodging: $1,276 · Education: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,118.15 |
| Travel and Lodging | $1,276.37 |
| Education | $367.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,415.60 | 2024-2025 | Endurant Iis, Hawkone |
| Stryker Corporation | $424.61 | 2025 | Flowtriever, Artix Mt, Clottriever Bold Catheter |
| W. L. Gore & Associates, INC. | $408.81 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Acuseal Vascular Graft, Gore Excluder Aaa Endoprosthesis |
| Endologix LLC | $353.56 | 2025 | Alto Abdominal Stent Graft System |
| Terumo Medical Corporation | $55.98 | 2025 | Navicross |
| Shockwave Medical, INC | $28.76 | 2025 | |
| Solventum Corporation | $25.93 | 2025 | Prevena |
| Neuros Medical, INC. | $18.16 | 2025 | Altius |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.83 | 2025 | Jardiance |
| Lemaitre Vascular, INC. | $14.89 | 2025 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Beyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.